替加环素成功治疗两例由产超广谱β-内酰胺酶大肠杆菌引起的复杂性尿路感染患者。 - Suppr

Suppr

超能文献

Successful treatment with tigecycline of two patients with complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

作者信息

Geerlings Suzanne E, van Donselaar-van der Pant Karlijn A M I, Keur Ingrid

出版信息

J Antimicrob Chemother. 2010 Sep;65(9):2048-9. doi: 10.1093/jac/dkq224. Epub 2010 Jun 16.

DOI:10.1093/jac/dkq224

PMID:20554566

Abstract

摘要

相似文献

Successful treatment with tigecycline of two patients with complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

J Antimicrob Chemother. 2010 Sep;65(9):2048-9. doi: 10.1093/jac/dkq224. Epub 2010 Jun 16.

Treatment with tigecycline of recurrent urosepsis caused by extended-spectrum-beta-lactamase-producing Escherichia coli.

J Clin Microbiol. 2008 Feb;46(2):817-20. doi: 10.1128/JCM.01340-07. Epub 2007 Dec 12.

Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.

Clin Exp Nephrol. 2019 Nov;23(11):1306-1314. doi: 10.1007/s10157-019-01775-w. Epub 2019 Aug 19.

Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?

J Hosp Infect. 2008 Feb;68(2):181-3. doi: 10.1016/j.jhin.2007.11.014. Epub 2008 Jan 14.

Fosfomycin susceptibility among extended-spectrum-beta-lactamase-producing Escherichia coli in Nottingham, UK.

J Antimicrob Chemother. 2010 May;65(5):1076-7. doi: 10.1093/jac/dkq051. Epub 2010 Feb 24.

Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.

J Antimicrob Chemother. 2006 Jun;57(6):1262-3. doi: 10.1093/jac/dkl102. Epub 2006 Mar 24.

Ciprofloxacin and co-trimoxazole resistance and extended spectrum beta-lactamase production in Escherichia coli strains isolated from urinary tract infections.

Int J Antimicrob Agents. 2003 May;21(5):492-3. doi: 10.1016/s0924-8579(03)00042-6.

Therapeutic options for bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Clin Infect Dis. 2010 Jul 1;51(1):119-20; author reply 120-1. doi: 10.1086/653446.

Co-production of MCR-1 and extended-spectrum β-lactamase in Escherichia coli recovered from urinary tract infections in Switzerland.

Infection. 2018 Feb;46(1):143-144. doi: 10.1007/s15010-017-1080-6. Epub 2017 Oct 19.

Community-acquired extended-spectrum beta-lactamase producers, United States.

Emerg Infect Dis. 2007 Jul;13(7):1121-3. doi: 10.3201/eid1307.070094.

引用本文的文献

Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient.

Front Transplant. 2025 Feb 18;3:1496702. doi: 10.3389/frtra.2024.1496702. eCollection 2024.

Role of tigecycline in the treatment of urinary tract infections: a systematic review of published case reports.

Infez Med. 2022 Dec 1;30(4):516-524. doi: 10.53854/liim-3004-5. eCollection 2022.

Role of Tigecycline for the Treatment of Urinary Tract Infections.

J Pharm Technol. 2014 Jun;30(3):87-92. doi: 10.1177/8755122513519332. Epub 2014 Jan 7.

Efficacy and safety of tigecycline for complicated urinary tract infection: a systematic review.

Transl Androl Urol. 2021 Jan;10(1):292-299. doi: 10.21037/tau-20-959.

Successful Treatment of Acute Prostatitis Caused by Multidrug-Resistant With Tigecycline Monotherapy.

Open Forum Infect Dis. 2020 Jan 9;7(1):ofz551. doi: 10.1093/ofid/ofz551. eCollection 2020 Jan.

Tigecycline treatment of urinary tract infection and prostatitis: case report and literature review.

Can J Hosp Pharm. 2012 May;65(3):209-15. doi: 10.4212/cjhp.v65i3.1144.

Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.

Antimicrob Agents Chemother. 2011 Dec;55(12):5893-9. doi: 10.1128/AAC.00387-11. Epub 2011 Oct 3.

Update in adult urinary tract infection.

Curr Infect Dis Rep. 2011 Dec;13(6):552-60. doi: 10.1007/s11908-011-0212-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Successful treatment with tigecycline of two patients with complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

作者信息

Geerlings Suzanne E, van Donselaar-van der Pant Karlijn A M I, Keur Ingrid

出版信息

J Antimicrob Chemother. 2010 Sep;65(9):2048-9. doi: 10.1093/jac/dkq224. Epub 2010 Jun 16.

DOI:10.1093/jac/dkq224

PMID:20554566

Abstract

摘要

相似文献

Successful treatment with tigecycline of two patients with complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

J Antimicrob Chemother. 2010 Sep;65(9):2048-9. doi: 10.1093/jac/dkq224. Epub 2010 Jun 16.

Treatment with tigecycline of recurrent urosepsis caused by extended-spectrum-beta-lactamase-producing Escherichia coli.

J Clin Microbiol. 2008 Feb;46(2):817-20. doi: 10.1128/JCM.01340-07. Epub 2007 Dec 12.

Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.

Clin Exp Nephrol. 2019 Nov;23(11):1306-1314. doi: 10.1007/s10157-019-01775-w. Epub 2019 Aug 19.

Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?

J Hosp Infect. 2008 Feb;68(2):181-3. doi: 10.1016/j.jhin.2007.11.014. Epub 2008 Jan 14.

Fosfomycin susceptibility among extended-spectrum-beta-lactamase-producing Escherichia coli in Nottingham, UK.

J Antimicrob Chemother. 2010 May;65(5):1076-7. doi: 10.1093/jac/dkq051. Epub 2010 Feb 24.

J Antimicrob Chemother. 2006 Jun;57(6):1262-3. doi: 10.1093/jac/dkl102. Epub 2006 Mar 24.

Ciprofloxacin and co-trimoxazole resistance and extended spectrum beta-lactamase production in Escherichia coli strains isolated from urinary tract infections.

Int J Antimicrob Agents. 2003 May;21(5):492-3. doi: 10.1016/s0924-8579(03)00042-6.

Therapeutic options for bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Clin Infect Dis. 2010 Jul 1;51(1):119-20; author reply 120-1. doi: 10.1086/653446.

Co-production of MCR-1 and extended-spectrum β-lactamase in Escherichia coli recovered from urinary tract infections in Switzerland.

Infection. 2018 Feb;46(1):143-144. doi: 10.1007/s15010-017-1080-6. Epub 2017 Oct 19.

Community-acquired extended-spectrum beta-lactamase producers, United States.

Emerg Infect Dis. 2007 Jul;13(7):1121-3. doi: 10.3201/eid1307.070094.

引用本文的文献

Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient.

Front Transplant. 2025 Feb 18;3:1496702. doi: 10.3389/frtra.2024.1496702. eCollection 2024.

Role of tigecycline in the treatment of urinary tract infections: a systematic review of published case reports.

Infez Med. 2022 Dec 1;30(4):516-524. doi: 10.53854/liim-3004-5. eCollection 2022.

Role of Tigecycline for the Treatment of Urinary Tract Infections.

J Pharm Technol. 2014 Jun;30(3):87-92. doi: 10.1177/8755122513519332. Epub 2014 Jan 7.

Efficacy and safety of tigecycline for complicated urinary tract infection: a systematic review.

Transl Androl Urol. 2021 Jan;10(1):292-299. doi: 10.21037/tau-20-959.

Successful Treatment of Acute Prostatitis Caused by Multidrug-Resistant With Tigecycline Monotherapy.

Open Forum Infect Dis. 2020 Jan 9;7(1):ofz551. doi: 10.1093/ofid/ofz551. eCollection 2020 Jan.

Tigecycline treatment of urinary tract infection and prostatitis: case report and literature review.

Can J Hosp Pharm. 2012 May;65(3):209-15. doi: 10.4212/cjhp.v65i3.1144.

Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.

Antimicrob Agents Chemother. 2011 Dec;55(12):5893-9. doi: 10.1128/AAC.00387-11. Epub 2011 Oct 3.

Update in adult urinary tract infection.

Curr Infect Dis Rep. 2011 Dec;13(6):552-60. doi: 10.1007/s11908-011-0212-x.